Detalhe da pesquisa
1.
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
J Neurooncol
; 168(1): 69-76, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551747
2.
Therapeutic drug monitoring of osimertinib in EGFR mutant non-small cell lung cancer by dried blood spot and plasma collection: A pilot study.
Br J Clin Pharmacol
; 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706157
3.
A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma.
Ther Drug Monit
; 46(3): 332-343, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263583
4.
CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review.
Curr Issues Mol Biol
; 45(7): 5276-5292, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504251
5.
Carer preparedness improved by providing a supportive educational intervention for carers of patients with high-grade glioma: RCT results.
J Neurooncol
; 161(3): 501-513, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658381
6.
Leptomeningeal neuraxis relapse in glioblastoma is an uncommon but not rare event associated with poor outcome.
BMC Neurol
; 23(1): 328, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715122
7.
Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma-A Case Report and Systematic Review.
Curr Issues Mol Biol
; 44(10): 5117-5125, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286062
8.
Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy.
BMC Neurol
; 22(1): 24, 2022 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027006
9.
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 22(6): 813-823, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000245
10.
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
; 141(6): 945-957, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740099
11.
Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Cochrane Database Syst Rev
; 5: CD013238, 2020 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32395825
12.
Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma.
Cancer
; 125(19): 3457-3466, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251406
13.
Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
BMC Cancer
; 19(1): 445, 2019 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31088401
14.
Identifying key needs for the integration of social-ecological outcomes in arctic wildlife monitoring.
Conserv Biol
; 33(4): 861-872, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30471146
15.
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Lancet
; 390(10103): 1645-1653, 2017 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801186
16.
Wildlife species benefitting from a greener Arctic are most sensitive to shrub cover at leading range edges.
Glob Chang Biol
; 24(1): 212-223, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28731522
17.
Anti-angiogenic therapy for high-grade glioma.
Cochrane Database Syst Rev
; 11: CD008218, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30480778
18.
The development of a district nursing caseload review tool.
Br J Community Nurs
; 23(6): 272-278, 2018 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869909
19.
The development of a district nursing caseload review tool.
Br J Community Nurs
; 23(6): 220-226, 2018 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29799777
20.
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
Cancer
; 123(18): 3576-3582, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28678383